Epidemiological and Clinical Characteristics of Non-Typhoidal Salmonella Bloodstream Infections in Central Israel: A Case-Control Study
Abstract
:1. Introduction
2. Methods
2.1. Setup and Study Design
2.2. Microbiological Methods and Definitions
2.3. Data Collection and Analysis
2.4. Ethical Statement
2.5. Power Calculations
3. Results
3.1. Demographic and Clinical Features of Patients with NTS-BSI vs. Control Groups
3.2. Microbiological Features of NTS-BSI Isolates
3.3. Treatment and Outcome of NTS-BSI Patients
4. Discussion
5. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
References
- Stanaway, J.D.; Parisi, A.; Sarkar, K.; Blacker, B.F.; Reiner, R.C.; Hay, S.I.; Nixon, M.R.; Dolecek, C.; James, S.L.; Mokdad, A.H.; et al. The Global Burden of Non-Typhoidal Salmonella Invasive Disease: A Systematic Analysis for the Global Burden of Disease Study 2017. Lancet Infect. Dis. 2019, 19, 1312–1324. [Google Scholar] [CrossRef]
- Dhanoa, A.; Fatt, Q.K. Non-Typhoidal Salmonella Bacteraemia: Epidemiology, Clinical Characteristics and Its’ Association with Severe Immunosuppression. Ann. Clin. Microbiol. Antimicrob. 2009, 8, 15. [Google Scholar] [CrossRef] [PubMed]
- Medalla, F.; Gu, W.; Mahon, B.E.; Judd, M.; Folster, J.; Griffin, P.M.; Hoekstra, R.M. Estimated Incidence of Antimicrobial Drug—Resistant Nontyphoidal Salmonella. Emerg. Infect. Dis. 2017, 23, 2004–2012. [Google Scholar]
- Bassal, R.; Reisfeld, A.; Andorn, N.; Yishai, R.; Nissan, I.; Agmon, V.; Peled, N.; Block, C.; Keller, N.; Kenes, Y.; et al. Recent Trends in the Epidemiology of Non-Typhoidal Salmonella in Israel, 1999-2009. Epidemiol. Infect. 2012, 140, 1446–1453. [Google Scholar] [CrossRef] [PubMed]
- Katz, D.; Ben-Chetrit, E.; Sherer, S.S.; Cohen, D.; Muhsen, K. Correlates of Non-Typhoidal Salmonella Bacteraemia: A Case–control Study. Int. J. Infect. Dis. 2019, 81, 170–175. [Google Scholar] [CrossRef] [PubMed]
- Varga, C.; Pearl, D.L.; McEwen, S.A.; Sargeant, J.M.; Pollari, F.; Guerin, M.T. Evaluating area-level spatial clustering of Salmonella Enteritidis infections and their socioeconomic determinants in the greater Toronto area, Ontario, Canada (2007–2009): A retrospective population-based ecological study. BMC Public Health 2013, 13, 1078. [Google Scholar] [CrossRef] [PubMed]
- Arshad, M.M.; Wilkins, M.J.; Downes, F.P.; Rahbar, M.H.; Erskine, R.J.; Boulton, M.L.; Saeed, A.M. A registry-based study on the association between human salmonellosis and routinely collected parameters in Michigan, 1995–2001. Foodborne Pathog. Dis. 2007, 4, 16–25. [Google Scholar] [CrossRef] [PubMed]
- Mughini-Gras, L.; Pijnacker, R.; Duijster, J.; Heck, M.; Wit, B.; Veldman, K.; Franz, E. Changing epidemiology of invasive non-typhoid Salmonella infection: A nationwide population-based registry study. Clin. Microbiol. Infect. 2020, 26, 941.e9–941.e14. [Google Scholar] [CrossRef] [PubMed]
- Weinberger, M.; Agmon, V.; Yaron, S.; Nissan, I.; Peretz, C. Geographical variations in Salmonella incidence in Israel 1997–2006: The effect of rural residency. Epidemiol. Infect. 2013, 141, 2058–2067. [Google Scholar] [CrossRef] [PubMed]
- Leber, A.L. Clinical Microbiology Procedures Handbook, 4th ed.; Leber, A.L., Ed.; ASM Press: Washington, DC, USA, 2016; ISBN 9781555818807. [Google Scholar]
- The Clinical and Laboratory Standards Institute. M100S Performance Standards for Antimicrobial Susceptibility Testing; The Clinical and Laboratory Standards Institute: Wayne, PA, USA, 2016. [Google Scholar]
- Charlson, M.E.; Pompei, P.; Ales, K.L.; MacKenzie, C.R. A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation. J. Chronic Dis. 1987, 40, 373–383. [Google Scholar] [CrossRef]
- Abramson, J.H. WINPEPI updated: Computer programs for epidemiologists, and their teaching potential. Epidemiol. Perspect. Innov. 2011, 8, 1. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Zaidenstein, R.; Peretz, C.; Nissan, I.; Reisfeld, A.; Yaron, S.; Agmon, V.; Weinberger, M. The Epidemiology of Extraintestinal Non-Typhoid Salmonella in Israel: The Effects of Patients’ Age and Sex. Eur. J. Clin. Microbiol. Infect. Dis. 2010, 29, 1103–1109. [Google Scholar] [CrossRef]
- Israeli Ministry of Health. Central Laboratories Report 2020; Israeli Ministry of Health: Jerusalem, Israel, 2020. [Google Scholar]
- Shimoni, Z.; Pitlik, S.; Leibovici, L.; Samra, Z.; Konigsberger, H.; Drucker, M.; Agmon, V.; Ashkenazi, S.; Weinberger, M. Nontyphoid Salmonella Bacteremia: Age-Related Differences in Clinical Presentation, Bacteriology, and Outcome. Clin. Infect. Dis. 1999, 28, 822–827. [Google Scholar] [CrossRef]
- Brown, M.; Eykyn, S.J. Non-Typhoidal Salmonella Bacteraemia without Gastroenteritis: A Marker of Underlying Immunosuppression. Review of Cases at St. Thomas’ Hospital 1970–1999. J. Infect. 2000, 41, 256–259. [Google Scholar] [CrossRef] [PubMed]
- The Clinical and Laboratory Standards Institute. M100 Performance Standards for Antimicrobial Susceptibility Testing 2020, 30th ed.; The Clinical and Laboratory Standards Institute: Wayne, PA, USA, 2020. [Google Scholar]
Variable | NTS 1-BSI 2 (n = 34) | NTS-GE 3 (n = 69) | E. coli BSI (n = 68) | p-Value |
---|---|---|---|---|
Gender, male, n (%) | 22 (64) | 36 (52) | 32 (47) | NS 4 |
Age, median (95% C.I.) | 59 (24, 75) | 59 (21, 75) | 62 (25, 73) | NS 4 |
0–19 years, n (%) | 7 (20) | 17 (25) | 14 (21) | |
20–59 years, n (%) | 12 (35) | 18 (26) | 16 (23) | |
≥60 years, n (%) | 15 (45) | 34 (49) | 38 (56) | |
Ethnicity, Jewish, n (%) | 30 (88) | 65 (100) | 56 (84) | <0.05 5 |
Recent (2 weeks) emergency room visit, n (%) | 1 (3) | 3 (4) | 2 (3) | NS 4 |
Recent (2 weeks) hospital admission, n (%) | 4 (12) | 5 (7) | 1 (1.5) | <0.05 6 |
Recent (2 weeks) antimicrobial use, n, (%) | 7 (21) | 4 (5.9) | 9 (13.6) | <0.05 5 |
Charlson Comorbidity Index, mean (SD) | 2.35 (2.84) | 1.78 (2.36) | 2.43 (2.92) | NS |
Past malignancy, n (%) | 8 (24) | 9 (13) | 18 (27) | NS |
Steroid use, n (%) | 6 (18) | 6 (8) | 5 (7) | NS |
Variable | NTS 1-BSI 2 (n = 34) | NTS-GE 3 (n = 69) | E. coli BSI (n = 68) | p-Value |
---|---|---|---|---|
Fever | 9 (45) | 27 (63) | 31 (84) | NS 4 |
Diarrhea | 17 (53) | 55 (80) | 8 (12) | <0.001 6 |
Emesis | 6 (19) | 27 (39) | 16 (24) | <0.05 5 |
Mean hemoglobin levels (g/dL) | 10.4 | 12.7 | 10.75 | <0.001 5 |
C-reactive protein concentration (mg/L) | 134 | 88 | 147 | <0.05 5 |
Neutrophil ratio (%) | 78 | 78 | 77 | NS 4 |
Platelets count (cpm) | 230,000 | 240,000 | 228,000 | NS 4 |
Variable | NTS 1-BSI 2 (n = 34) | NTS-GE 3 (n = 69) | E. coli BSI (n = 68) | p-Value |
---|---|---|---|---|
In-hospital death, n (%) | 8 (23) | 3 (4) | 13 (19) | <0.01 4 |
ICU transfer, n (%) | 0 | 0 | 1 (1.5) | NS |
Length of stay, median (95% C.I.) | 8 (1, 371) | 4 (0, 33) | 7 (1, 75) | <0.001 4 |
Recurrent admission within a year, n (%) | 1 (3) | 2 (3) | 1 (2) | NS 5 |
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Israel, Y.; Muhsen, K.; Rokney, A.; Adler, A. Epidemiological and Clinical Characteristics of Non-Typhoidal Salmonella Bloodstream Infections in Central Israel: A Case-Control Study. Microorganisms 2022, 10, 1942. https://doi.org/10.3390/microorganisms10101942
Israel Y, Muhsen K, Rokney A, Adler A. Epidemiological and Clinical Characteristics of Non-Typhoidal Salmonella Bloodstream Infections in Central Israel: A Case-Control Study. Microorganisms. 2022; 10(10):1942. https://doi.org/10.3390/microorganisms10101942
Chicago/Turabian StyleIsrael, Yael, Khitam Muhsen, Assaf Rokney, and Amos Adler. 2022. "Epidemiological and Clinical Characteristics of Non-Typhoidal Salmonella Bloodstream Infections in Central Israel: A Case-Control Study" Microorganisms 10, no. 10: 1942. https://doi.org/10.3390/microorganisms10101942